Do COVID-19 infections result in a different form of secondary hemophagocytic lymphohistiocytosis

R Chu, C van Eeden, S Suresh, WI Sligl… - International journal of …, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant morbidity and mortality …

Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?

V Opoka-Winiarska, E Grywalska, J Roliński - BMC medicine, 2020 - Springer
Background COVID-19, a disease caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), commonly presents as fever, cough, dyspnea, and myalgia or …

Assessment of the hemophagocytic lymphohistiocytosis HScore in patients with coronavirus disease 2019

KEN Clark, WD Nevin, T Mahungu… - Clinical Infectious …, 2021 - academic.oup.com
The clinical manifestation of moderate to severe coronavirus disease 2019 (COVID-19) has
parallels to secondary hemophagocytic lymphohistiocytosis (HLH) both clinically and based …

[HTML][HTML] Incidence of secondary hemophagocytic lymphohistiocytosis in critically-ill COVID-19 patients

J Allen, MM McCambridge, H Kincaid, JA Kalter - Cureus, 2021 - ncbi.nlm.nih.gov
Objective Coronavirus disease 2019 (COVID-19) is associated with diffuse lung injury that
can progress to acute respiratory distress syndrome, multisystem-organ failure, and death …

Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients

NN Hakim, J Chi, C Olazagasti… - … Biology and Medicine, 2021 - journals.sagepub.com
COVID-19 or SARS-CoV-2 infection can lead to severe acute respiratory distress
syndrome/pneumonia with features of cytokine storm reminiscent of secondary …

Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?

JM Liu, J Chi - Experimental Biology and Medicine, 2022 - journals.sagepub.com
Cytokine storm is an umbrella term that describes an inflammatory syndrome characterized
by elevated levels of circulating cytokines and hyperactivation of innate and/or adaptive …

Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients

M Meng, L Chen, S Zhang, X Dong, W Li, R Li… - BMC Infectious …, 2021 - Springer
Background Secondary hemophagocytic lymphohistiocytosis (sHLH) is a life-threatening
hyperinflammatory event and a fatal complication of viral infections. Whether sHLH may also …

Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection

K Dewaele, R Claeys - Blood, 2020 - ncbi.nlm.nih.gov
A previously healthy 55-year-old woman presented with fever, malaise, and a mild cough.
Chest radiograph revealed bilateral patchy infiltrates. A nasopharyngeal swab tested …

[HTML][HTML] Hemophagocytic lymphohistiocytosis in COVID-19: case reports of a stepwise approach

S Schnaubelt, D Tihanyi, R Strassl, R Schmidt… - Medicine, 2021 - journals.lww.com
Interventions: A treatment regimen of methylprednisolone, pentaglobin, and anakinra was
developed and administered. Outcomes: One patient survived the ICU stay. Two other …

[HTML][HTML] Secondary hemophagocytic lymphohistiocytosis in post-COVID-19 patients: a report of two cases

P Kalita, D Laishram, B Dey, J Mishra, B Barman… - Cureus, 2021 - ncbi.nlm.nih.gov
Hemophagocytic lymphohistiocytosis (HLH) is a disease that can affect both children and
adults. HLH can be categorized as primary or secondary. Secondary HLH (sHLH) may be …